Click here to view the Blue Cross Blue Shield BCBS Louisiana Medical Policy Updates »…
BCBS Louisiana Medical Policy Updates – December 2024
Stay ahead in medical policy monitoring and tracking with personalized reports and a real-time dashboard tailored to specific products, procedures, or codes. For those seeking a more impactful solution than Policy Reporter, our platform delivers comprehensive data analytic tools, user-friendly dashboard and collaboration features, client-focused solutions, and real-time email alerts.
Schedule a demo to see how our focused reports save time and provide actionable insights for your reimbursement and commercialization efforts.
Click here to view the Blue Cross Blue Shield BCBS Louisiana Medical Policy Updates »
December 2024 BCBS Louisiana Medical Policy Updates:
- Ambulatory Event Monitors and Mobile Cardiac Outpatient Telemetry
- anifrolumab (Saphnelo™)
- Automated Percutaneous and Percutaneous Endoscopic Discectomy
- Autonomic Nervous System Testing
- brodalumab (Siliq™)
- C1 esterase inhibitor [recombinant] (Ruconest®)
- cholic acid capsules (Cholbam™)
- Delandistrogene Moxeparvovec-rokl (Elevidys®)
- deucravacitinib (Sotyktu )
- Digital Health Therapies for Substance Abuse
- Drug-Eluting Sinus Stents and Implants for Postoperative Use Following Endoscopic Sinus Surgery and for Recurrent Sinonasal Polyposis
- Endovascular Procedures for Intracranial Arterial Disease (Atherosclerosis and Aneurysms)
- Entadfi (finasteride and tadalafil)
- Eucrisa™ (crisaborole)
- Fecal Microbiota Spores, live-brpk (Vowst™)
- Helidac® (bismuth subsalicylate, metronidazole, tetracycline)
- Hyperbaric Oxygen Pressurization (HBO)
- Islet Transplantation
- ivacaftor (Kalydeco™)
- Kerendia® (finerenone)
- Lanreotide Products
- Laser Treatment of Acne and Rosacea
- Leniolisib (Joenja®)
- Lucemyra™ (lofexidine)
- lumacaftor/ivacaftor (Orkambi)™
- Lung and Lobar Lung Transplant
- Lyrica CR®, generics (pregabalin extended release)
- Metformin and Metformin Containing Products
- Nasal Allergy Medications
- nitisinone (Orfadin®, Nityr™, generics)
- obeticholic acid (Ocaliva®
- Osilodrostat (Isturisa®)
- Ovarian and Internal Iliac Vein Endovascular Occlusion as a Treatment of Pelvic Congestion Syndrome
- pegvaliase-pqpz (Palynziq™)
- Pharmacologic Treatment of Off Episodes in Parkinson Disease
- Pharmacotherapy for Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease
- Prostatic Urethral Lift
- Romosozumab-Aqqg (Evenity™)
- sirolimus topical gel (Hyftor )
- Small Bowel Transplant, Small Bowel/Liver Transplant and Multivisceral Transplant
- Total Artificial Hearts and Implantable Ventricular Assist Devices
- Treatment of Hepatitis C with ombitasvir, paritaprevir, ritonavir, and dasabuvir (Viekira Pak™)
- Treatment of Hepatitis C with sofosbuvir/velpatasvir/voxilaprevir (Vosevi™)
- Treatment of Varicose Veins/Venous Insufficiency
- Urea Cycle Disorder Pharmacologic Agents (Buphenyl®, Ravicti®, generics)
- Ustekinumab (Stelara®)
- Valoctocogene Roxaparvovec-rvox (Roctavian™)
- Vivjoa (oteseconazole)
- Voquezna® (vonoprazan)
- Zegalogue® (dasiglucagon)
- Zerviate™ (Cetirizine Ophthalmic Solution)
How Does Policy Alerts Work?
Policy Alerts’ medical policy monitoring and alerts software continuously monitors Commercial, Medicare, and Medicaid coverage information to keep you up-to-date on coverage changes in real-time.
Policy Alerts’ software locates relevant Payer medical policies and coverage information from across the web. This software monitors that information for updates and changes while also searching for new medical policies and coverage information. Whenever changes occur, Policy Alerts immediately sends out an email notification containing a summary of what has changed.
Clients can access their medical policies and payer coverage summary on the interactive Policy Alerts dashboard. Never miss another important insurance carrier medical policy review or coverage decision update again!
✓ Thousands of subscribers ✓ Easy setup
Related Posts
